← Open Payments lookup

JENNIFER LANDRETTE: Open Payments

NPI 1609193671 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,109 in 55 payments from 10 companies in 2025. Trend: 2023 $101 · 2024 $264 · 2025 $1,109

Food & beverage: $1,109
CompanyPaymentsAmount
Alkermes, Inc.15$230
E.R. Squibb & Sons, L.L.C.16$216
Neurocrine BioSciences, Inc.5$158
Janssen Pharmaceuticals, Inc3$130
Teva Pharmaceuticals USA, Inc.5$119
Vanda Pharmaceuticals Inc.3$90
ABBVIE INC.3$52
Otsuka America Pharmaceutical, Inc.2$47
Lundbeck LLC2$38
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28

Products named: ARISTADA, COBENFY, INGREZZA, INVEGA SUSTENNA, FANAPT, ABILIFY ASIMTUFII, UZEDY, VRAYLAR.

Industry payments across DC — which companies pay providers there.